CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR)

CUSIP: 17331Y109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common stock, $0.0001 par value
Shares outstanding
80,864,905
Total 13F shares
200,884
Share change
+159,646
Total reported value
$230,191
Price per share
$1.15
Number of holders
11
Value change
+$180,602
Number of buys
7
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 17331Y109?
CUSIP 17331Y109 identifies CTOR - CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) as of Q4 2024

As of 31 Dec 2024, CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 200,884 shares. The largest 10 holders included HRT FINANCIAL LP, UBS Group AG, CITADEL ADVISORS LLC, IFP Advisors, Inc, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, Yakira Capital Management, Inc., RENAISSANCE TECHNOLOGIES LLC, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.